Related by context. All words. (Click for frequent words.) 79 -#.# mg dL [002] 74 baseline serum creatinine 73 titrated glipizide plus 73 #.#/#.# mmHg [001] 72 prednisone prednisolone plus 71 lumbar spine BMD 71 glipizide plus 70 -#.# log# 70 #.#mg/dL 70 fasting plasma glucose FPG 70 oxycodone CR 69 TAXUS p value 69 PROCTOCORT ® Suppository Hydrocortisone 69 log# copies mL 69 plus glimepiride 68 Acetate Rectal Suppositories 68 CI -#.# 68 baseline HbA1c 68 lispro 67 moderate renal impairment 67 mg TID 67 placebo p 67 infliximab monotherapy 67 total cholesterol triglycerides 67 confidence interval #.#-#.# 67 lopinavir r arm 67 Cream USP 1 66 -#.# mm Hg 66 % Confidence Interval 66 Mg Uk 66 #-#,# mg 66 mcg QD 66 oxycodone IR 66 -#.# ± [002] 66 neuropathy sensory 66 hip BMD 66 alanine aminotransferase 66 log# IU mL 66 mitoxantrone plus 66 -#.# log# copies mL 66 -#.# mmHg 66 plus OBT 66 Secondary endpoints included 66 mmHg diastolic 66 Hazard Ratio HR 66 achieved ACR# 66 Fasting blood glucose 66 Mg Usa 66 placebo p = 66 HDL LDL ratio 66 TOTAL REV 66 nonsignificant difference 65 HDL Cholesterol 65 plus prednisone prednisolone 65 serologically active patients 65 HbA1C levels 65 morphometric vertebral fractures 65 budesonide pMDI 65 #.#mmol L [001] 65 CYP#A# substrate 65 baseline A1C 65 mg + GLY 65 triglyceride TG 65 CDAI score 65 P = .# 65 FUSILEV enhances 65 mg kg belimumab 65 HOMA IR 65 creatinine ratio 65 CI #.#-#.# [002] 65 XIENCE V vs. 65 LDL cholesterol HDL cholesterol 65 tapentadol IR 65 echocardiographic parameters 65 CYP#A# CYP#D# 65 serum triglycerides 65 stomatitis pharyngitis 65 Demonstrated Significant 65 ischemia driven 65 MADRS score 65 dapagliflozin plus 65 NPH insulin 65 apolipoprotein B 65 ADAS Cog 65 ALT elevation 65 aspirin clopidogrel 65 ATV RTV 65 Capacity FVC 65 albumin excretion rate 65 ADCS CGIC 65 mL/min/#.# m 2 65 -#.# ± [001] 64 ACR# ACR# 64 g trans fats 64 Zometa hazard 64 pill containing benazepril 64 mg BID dose 64 Crohn Disease Activity 64 plus methotrexate 64 PLX STROKE targeting 64 atorvastatin #mg 64 nondiabetic patients 64 Montgomery Asberg Depression 64 lumbar spine bone 64 acarbose 64 sUA 64 dalteparin 64 hematological parameters 64 BENICAR HCT 64 x ULN 64 -#.# mmol L 64 p = NS 64 AUC0 #hr 64 lipoprotein Lp 64 #mg/day [002] 64 glycosylated hemoglobin HbA1c 64 mmol l 64 plus GP IIb 64 Flu Cy 64 SGPT 64 SGOT 64 mcg BID 64 angiotensin II receptor blockers 64 Levels Linked 64 combines Zetia 64 HAQ DI 64 versus +9 64 achieved statistical significance 64 lopinavir r 64 serum phosphorous 64 Patients Receiving 64 intact parathyroid hormone 64 Index CDAI 64 #.#/#.# mm Hg [003] 64 linaclotide treated 64 nonfasting triglyceride levels 64 & s2 = 64 Ishak fibrosis score 63 paroxetine sertraline 63 dizziness nausea diarrhea 63 ACTEMRA TM 63 Scale cognitive subscale 63 comparator arm 63 plus prednisone 63 cells uL 63 MARKET TALK Saudi 63 rosuvastatin #mg 63 PASI scores 63 vitreous floaters 63 CrCl 63 trough FEV1 63 serum lipid 63 unfractionated heparin UFH 63 HBeAg negative patients 63 Oral Fingolimod 63 alfuzosin 63 8mg/kg 63 CR nPR 63 -# mg dL 63 + PH# 63 HBeAg seroconversion 63 urinary N telopeptide 63 specific alkaline phosphatase 63 XIENCE V PROMUS Stent 63 oral hypoglycemic agent 63 #.# ASIA ADRS [001] 63 Vildagliptin 63 #.#mmol L [002] 63 nicardipine 63 benazepril 63 alanine aminotransferase ALT 63 tolterodine ER 63 mg p = 63 headache nasopharyngitis 63 LDL triglycerides 63 mg metformin 63 quetiapine risperidone 63 plus MTX 63 Showed Significant 63 abacavir lamivudine 63 adjunctive placebo 63 PANSS total 63 Consensus +#.# 63 warfarin erythromycin 63 #.#mmHg 63 placebo PBO 63 Annualized ROE 63 stage IIIb IV 63 thrombosis embolism 63 Pharmacokinetic parameters 63 Posaconazole 63 DJI #.# 63 0mg 62 dose pravastatin 62 5 FU leucovorin 62 ACR# responses 62 humanized interleukin 6 62 Hb A1C 62 echinacea tablets 62 Hazard Ratio 62 azilsartan medoxomil 62 insulin sulfonylureas 62 4mg/kg 62 nonvertebral 62 umol L 62 Severity MSCS score 62 ® fluocinonide Cream 62 Median PFS 62 mg qd 62 ACR# response 62 Suppository Hydrocortisone Acetate Rectal 62 #mg BID [001] 62 multivariable adjusted 62 diastolic BP 62 ATACAND 62 receiving XGEVA 62 3mg/kg 62 liver histology 62 rimonabant #mg 62 -#.# USD JPY [002] 62 REMICADE monotherapy 62 R adefovir dipivoxil 62 HUL +#.# 62 Adjusted EBITDAR margin 62 hemoglobin A1c HbA1c 62 mmHg p = 62 myocardial infarction ventricular fibrillation 62 glycated hemoglobin HbA1c 62 serum triglyceride levels 62 atheroma volume 62 Alzheimer Disease Assessment 62 -#.# USD JPY [003] 62 ALVESCO 62 malignancy HCM 62 #mg #mg #mg [003] 62 rosuvastatin Crestor 62 Rating Scale MADRS 62 HbA1C 62 insomnia somnolence 62 #mg/day [001] 62 mU liter 62 CI #.#-#.# [001] 62 pooled comparator 62 lactate dehydrogenase LDH 62 mg tid 62 lowest tertile 62 protein excretion 62 CHF +#.# 62 plus dexamethasone 62 H2RAs 62 left ventricular diastolic 62 pyrexia mucositis sepsis febrile 62 venlafaxine XR 62 BARACLUDE r 62 Adefovir 62 intracranial atherosclerosis 62 mg hydrochlorothiazide 62 unresectable HCC 62 certolizumab 62 AUA Symptom Score 62 placebo fluoxetine 62 Fasting plasma glucose 62 lispro alone 62 adjunctive ABILIFY 62 tamoxifen Nolvadex ® 62 OS = ISD/#/#/# 62 statin monotherapy 62 sulfonylurea metformin 62 zonisamide SR 62 International Prostate Symptom 62 interleukin IL -6 62 PANSS scores 62 highest tertile 62 PREZISTA r arm 62 serum aminotransferase levels 62 IPSS 62 GlaxoSmithKline Advair Diskus 62 ADAS cog 62 pg ml 62 somatostatin analog 62 rectal tenesmus #.# 62 humanized therapeutic 61 mild renal insufficiency 61 salmeterol fluticasone propionate 61 triglyceride concentrations 61 mso footer margin 61 binary restenosis 61 #mg BID [003] 61 μg d 61 clodronate 61 DOWNGRADE ALERT WATCH FOR 61 pulmonary capillary wedge 61 Relapsing Multiple Sclerosis 61 serum urate 61 nmol liter 61 baseline FEV 61 mg XP# 61 pmol L 61 glucose insulin 61 % CI #.#-#.# [003] 61 WOMAC pain 61 beta 1a 61 candesartan cilexetil 61 HbA 1c 61 placebo dexamethasone 61 titrated glipizide 61 #mg/dL [001] 61 plasma leptin 61 relapsed MM 61 SLE Responder Index 61 irinotecan cisplatin 61 p = .# [002] 61 CIMZIA TM 61 FOLFIRI alone 61 Demonstrate Significant 61 deep venous thromboses 61 BUPHENYL R sodium phenylbutyrate 61 serum urate levels 61 plasma lipids 61 extrapyramidal symptoms 61 Apolipoprotein B 61 Global Nonlife Insurance 61 myalgia muscle 61 tirofiban 61 STRATEGY FOR AN OPEN 61 ritonavir boosted 61 mmHg systolic 61 mL/min/#.# m2 61 Maruti Suzuki -#.# 61 Meets Primary Endpoint 61 % MID-EAST/AFRICA 61 plus aztreonam 61 ACE Inhibitors 61 aspartate aminotransferase AST 61 aminotransferases 61 REYATAZ r arm 61 YESTERDAY 'S SELLOFF OF 61 rectal tenesmus 61 DG# compounds targeting 61 fatigue asthenia 61 See CLINICAL PHARMACOLOGY 61 #.#/#.# mm Hg [002] 61 hydroxymethyl coenzyme 61 receiving prophylactic anticoagulation 61 impaired glucose metabolism 61 elevated serum creatinine 61 fasting insulin 61 p = ns 61 dose atorvastatin 61 ASIA ADRS 61 Delivery Starts 61 mg simvastatin 61 baseline serum bilirubin 61 basal bolus therapy 61 ACE inhibitor benazepril 61 gadolinium enhancing lesions 61 salmeterol fluticasone 61 Adjuvant Treatment 61 MEXICAN PESO 61 bone marrow reticulin deposition 61 unresectable tumors 61 imiquimod cream 61 urinary albumin 61 mIU ml 61 fasting plasma glucose 61 intima media thickness 61 femoral neck BMD 61 pg mL 61 triglycerides TG 61 Taxus Stent 61 plus octreotide LAR 61 detemir 61 HbA 1c levels 61 SELECT SECTOR SPDR FUND 61 Novel Inhibitor 61 CIMZIA ™ 61 p = #.# [004] 61 hormone receptor negative 61 0 document.write 61 moderate hepatic impairment 61 confidence intervals CIs 61 glycosylated hemoglobin levels 61 #R #R #R [002] 61 seropositive patients 61 -#.# DOW JONES 61 LME Alum #.# 61 fasting serum 61 Endocrine Therapy 61 non squamous histology 61 T2 lesion volume 61 N telopeptide 61 arterial thromboembolic events 61 TO PULLBACK AFTER GAINING 61 Lipitor #mg 61 annualized relapse 61 Unfractionated Heparin 61 FDA defined valvulopathy 60 #.# #.# -#.# [002] 60 receiving ISENTRESS 60 zoledronic acid Reclast 60 5-FU/LV 60 FluCAM 60 Folfox 60 fluvastatin Lescol 60 glulisine 60 serum phosphate 60 glycosylated hemoglobin 60 Tasigna prolongs 60 mcg kg REBETOL 60 desvenlafaxine succinate 60 mean baseline A1C 60 hemoglobin A1c levels 60 lactate dehydrogenase 60 DAS# scores 60 cisplatin gemcitabine 60 tipranavir r 60 EGYPTIAN POUND 60 nmol l 60 triglycerides HDL 60 ritonavir boosted atazanavir 60 epoetin alpha 60 paricalcitol 60 % #lt ;/ 60 aspartate aminotransferase 60 Psoriasis Area 60 Lopid 60 PSA nadir 60 TLUS 60 serum potassium 60 #mg/dL [002] 60 aOR 60 mineral density BMD 60 Apidra ® 60 % #gt 60 reduce serum phosphate 60 urine albumin 60 asthenia fatigue 60 fructosamine 60 glycaemia 60 adenoma recurrence 60 NNT = 60 calculated creatinine clearance 60 fractional shortening 60 BSE SMALLCAP index 60 mm Hg diastolic 60 YY =Anders Ostergaard 60 elevated ALT 60 Nonoperating expense 60 scores TNSS 60 elevated lipase 60 #mg sodium #mg [001] 60 plus glycoprotein IIb 60 biochemical relapse 60 MADRS 60 mso header 60 diameter stenosis 60 J Am Coll 60 glycated hemoglobin levels 60 Fibromyalgia Impact Questionnaire 60 hip femoral neck 60 elevated fasting glucose 60 receiving INTRON 60 Index AMBGNL closed 60 doxazosin 60 p = .# [001] 60 YMRS 60 apolipoprotein E4 60 UACR 60 FOLFOX4 60 Key secondary endpoints 60 Average Stockholders Equity 60 complete cytogenetic response 60 0 mg chol 60 glimepiride 60 ARB telmisartan 60 urinary cortisol 60 TO TOTAL LOANS 60 HDL glucose 60 Known hypersensitivity 60 confidence interval CI 60 ug dose 60 serum CRP 60 Thal Dex 60 bivalirudin monotherapy 60 BENICAR 60 bioavailable testosterone 60 oral antidiabetes 60 Cmax 60 Drug eluting stent 60 % CI #.#-#.# [006] 60 ® Liberte 60 TICKER HOME SUPPLY TOTAL 60 neutropenia thrombocytopenia 60 Peginterferon Alfa 2a 60 grams dietary fiber 60 CIMZIA TM certolizumab pegol 60 Aranbee Pop Orchestra 60 irbesartan 60 Non inferiority 60 True Width CL 60 biphasic insulin aspart 60 HER2 expression 60 PRADAXA #mg 60 Network Uptime Money 60 Prostate Cancer Recurrence 60 Operative mortality 60 STELARA ® 60 oral antidiabetic medication 60 substantially excreted 60 -#.# CBOT soy [002] 60 hyperphenylalaninemia HPA due 60 mg QD 60 lipid parameters 60 IDFC +#.# 60 Negative Syndrome 60 bortezomib refractory 60 cyclophosphamide methotrexate 60 risedronate 60 â ‰ ¥ 60 RATIO OF 60 mg ustekinumab 60 #.# #.# -#.# [001] 60 SET TO REBOUND AFTER 60 Shows Efficacy 60 Treatment Naive Patients 60 metformin IR 60 visceral adiposity 60 abnormal p# biomarker 60 adalimumab Humira 60 PEGylated anti 60 #ng/ml 60 Recurring prft 60 Cystatin C 60 C Reactive Protein 60 WEEK ENDING INDEX 60 fasting triglyceride levels 60 1mg 2mg 60 creatinine clearance 60 statistically significant p = 60 Sustained virologic response 60 severe renal impairment 60 anaphylactic reactions bronchospasm 60 CHANGE WEEKLY CHANGE 60 Platelet counts 60 interleukin IL -# 60 N Engl J 60 hypercholesterolaemia 60 tapentadol ER 60 mTSS 59 Statistically Significant 59 FOLFOX4 alone 59 Invasive Breast Cancer 59 Prognostic significance 59 RUSSIA SWAP 59 MCXCOMDEX trades 59 mg Lucentis 59 estrogen receptor beta agonist 59 Lantus ® 59 CK # plasma concentrations 59 Biaxin clarithromycin 59 Secondary endpoints include 59 DXY #.# #.# 59 mL sec 59 Furnishings Household 59 Primary endpoints 59 IDFC -#.# 59 brand ciclesonide HFA 59 SHARES SLIDING LOWER DOWN 59 drotrecogin alfa activated 59 thromboxane A2 59 preintervention 59 mg subcutaneous 59 Relapsed Refractory Multiple Myeloma 59 SHARES CREEPING HIGHER UP 59 Subclinical 59 R# #mg BID 59 BHEL -#.# 59 transaminases 59 Double Blind Randomized 59 SELENA SLEDAI score 59 serum lipid levels 59 #mmHg [001] 59 fasting triglycerides 59 HUL -#.# 59 efavirenz EFV 59 LDL cholesterol triglycerides 59 elevated triglyceride levels 59 blood glucose lipids 59 chlorambucil 59 DLF -#.# 59 racemic albuterol 59 Mean Symptom Complex 59 TIMP 1 59 shortens systolic ejection 59 TNF Tumor Necrosis Factor 59 Erythropoietic therapies may 59 avosentan 59 Sees FY# revs 59 ® zoledronic acid 59 BARACLUDE ® 59 fasting plasma 59 fluticasone salmeterol 59 0 len = 59 elevated hsCRP 59 SHARES DROP 59 IU mL 59 baseline LDH 59 undergoing androgen deprivation 59 experienced virologic failure 59 TO PULLBACK AFTER YESTERDAY 59 metabolic alkalosis 59 #.# ASIA ADRS [002] 59 DAS# remission 59 Host Disease 59 mmol liter 59 Crestor rosuvastatin 59 % CI #.#-#.# [005] 59 YEAR YEAR 59 splenectomized 59 IBDQ 59 Unit Handling Equipment 59 BPH Symptom Score 59 Pharmacokinetics PK 59 UltraShort QQQ ProShares PCX 59 receiving golimumab 59 μg kg 59 CYT# potent vascular disrupting 59 Score TOS 59 neutropenia dehydration dyspnea 59 cholesterol LDL C 59 ARCALYST ® 59 TO REBOUND AFTER 59 Fasting glucose 59 colorectal adenoma 59 Score IPSS 59 mm Hg systolic 59 Bone Metastases 59 Hb A1c 59 sitosterol 59 g carbo 59 channel blocker amlodipine 59 elevated LDL cholesterol 59 pct +#.# [002] 59 pct -#.# 59 elevated transaminases 59 glomerular filtration 59 * FLOOD STAGE 59 Homes Sold tbr 59 TAXUS Express Stent 59 elevated uric acid 59 doxorubicin cyclophosphamide 59 nitroprusside 59 hypophosphatemia 59 total cholesterol LDL 59 UNDER PRESSURE DOWN 59 #.#ng/ml 59 adriamycin 59 Forced Vital 59 pravastatin 59 QTcF 59 HDL cholesterol triglycerides 59 zoledronate 59 Desvenlafaxine Succinate 59 F FLT 59 left ventricular systolic 59 Pred Forte 59 hyperlipidaemia 59 -5 -6 59 baseline Hb 59 flutamide 59 plasma homocysteine 59 XP# Transported Prodrug 59 β blockers 59 EDARBI 59 0 document.write sline 59 Jaiprakash Assoc 59 fluticasone propionate FP 59 beta blocker atenolol 59 Prolongs Survival 59 STOCK RISES 59 saline placebo 59 NMIBC 59 5 Fluorouracil 59 achieved CCyR 59 stimulated insulin secretion 59 mineral density 59 beta carotene supplementation 59 SAID SELL 59 prolactin elevation 59 IIIa inhibitor 59 metformin sulfonylurea 59 FTE Avg 59 Fluticasone 59 refractory ischemia 59 diastolic blood pressures 59 nonfatal myocardial infarction 59 alanine transaminase 59 -#.# ASIA ADRS 59 μmol L 59 sitagliptin Januvia 59 statistically significant p 59 elevated alkaline phosphatase 59 leuprorelin 59 triacylglycerol concentrations 59 advanced adenoma 59 RPM ASM 59 Castration Resistant Prostate Cancer 59 Triglyceride levels 59 ALT normalization 59 mEq L 59 CYPHER R Sirolimus Eluting 59 metoprolol tartrate 59 mg subcutaneously 59 #.# SHFE Cu [002] 59 % CI #.#-#.# [007] 59 #-#.# BID 59 ® emtricitabine 59 glomerular filtration rate 59 pancreatic prostate 59 INVEGA ™ 59 TWD#.# [003] 59 piotr.skolimowski @ thomson.com 59 impaired endothelial 59 lowers triglycerides 59 rizatriptan 59 WOMAC TM 59 irinotecan doxorubicin oxaliplatin paclitaxel 59 nausea dizziness vomiting 59 ALIMTA cisplatin 59 #/#/# PriceWatch Alert Targets [001] 59 uM 59 Non Responders 59 serum magnesium 59 sumatriptan naproxen sodium 59 EMRG VIO 59 CCyR 59 SINCE REPORTING QUARTERLY RESULTS 59 ON SECURITIES 59 bleeding pallor 59 Navelbine 59 affective psychosis 59 dehydroepiandrosterone sulfate 59 tryptase 59 elements.length 59 HMG CoA reductase inhibitor 59 carotid artery intima media 59 Methotrexate MTX 59 TO POTENTIALLY PULLBACK AFTER 59 folate vitamin B6 59 highly emetogenic 59 ß = 59 TDF FTC 58 COMP SALES 58 lipid lowering agents 58 adefovir treated 58 p = #.# [002] 58 hypertrichosis occurred 58 insulin lispro 58 colesevelam 58 TAXUS Liberte Long 58 Glomerular Filtration Rate 58 p ≤ 58 Ki# 58 administered cetrorelix 58 IFL chemotherapy regimen 58 pravastatin therapy 58 FOLFOX6 58 rabeprazole 58 kilometers FTK 58 non splenectomized 58 LME Cu #.# -#.# [001] 58 mmol L 58 OGTT 58 HBeAg 58 serum phosphorus 58 ug kg 58 KRAS mutant tumors 58 GERD symptom 58 Brief Psychiatric 58 advanced adenomas 58 overt nephropathy 58 mcg linaclotide 58 Hazard Ratio = 58 abnormal p# 58 Modified EBITDA Margin 58 postmenopausal osteoporotic women 58 AGTR1 58 Lupuzor ™ 58 CRUDE CLc1 #.# 58 TNFalpha 58 progesterone receptor negative 58 cells mcL 58 bronchial hyperresponsiveness 58 Punt Returns Number 58 LANTUS R 58 GSTT1 58 Sensitivity specificity 58 postprandial insulin 58 Stainless Rod 58 g dl 58 hemodynamically significant 58 μmol l 58 #.# SHFE Cu [001] 58 serum creatinine levels 58 noninferior 58 PREZISTA ritonavir 58 clinically meaningful reductions 58 prolactin levels 58 Platinol ® cisplatin 58 KRAS mutations occur 58 Lucentis monotherapy 58 serum PTH 58 % SINCE UPTREND 58 Scale PANSS 58 primidone 58 Trades -#.# 58 SHARES GAIN 58 AUC0 58 baseline neutrophil counts 58 per deciliter mg 58 LME Zinc #.# -#.# 58 Viread Emtriva Sustiva 58 serum IGF 58 insulin detemir 58 plus medroxyprogesterone acetate 58 Xalatan R 58 LAB CGRP 58 Celsentri Selzentry 58 #.# Million Barrels [002] 58 change tbr -#.# 58 medroxyprogesterone acetate 58 mm Stent 58 confirmed CCyR 58 CYP#D# inhibitor 58 Hypomagnesemia occurred 58 Novel Compound 58 Free Survival PFS 58 n Cooling Degree 58 #.#g/day 58 #mg/dl 58 Cypher Stent 58 PSADT 58 tHcy 58 hepatic enzymes 58 glycated hemoglobin 58 methotrexate monotherapy 58 Budesonide foam crofelemer 58 Technical Downtrend Continuation 58 ABC/3TC 58 Montgomery Åsberg Depression 58 everolimus eluting stents 58 J Shoulder Elbow 58 urate lowering therapy 58 inflammatory lesions 58 HLA DR2 58 6MWD 58 EMBLEM TM 58 mg Androxal 58 AD.L Top 58 polyp recurrence 58 Randomized Double Blind 58 #Gy 58 APTIVUS r 58 Grasim Industries -#.# 58 RLAI 58 Renal Cell Carcinoma 58 neutropenia fatigue 58 neutrophil counts 58 LME Cu #.# -#.# [002] 58 progression TTP 58 R atorvastatin calcium 58 Myocardial Infarction Study 58 SET TO POSSIBLY REBOUND 58 Cystic Fibrosis Questionnaire Revised 58 Vasomotor Symptoms 58 Soriatane R acitretin capsules 58 lipid elevations 58 salmeterol inhalation powder 58 zolmitriptan 58 fraction LVEF 58 plasma renin activity 58 deCODE AF TM 58 postprandial glucose PPG 58 fatigue abdominal pain 58 STOCK FALLS 58 peginterferon alfa 2a 58 thickness CIMT 58 'S BUY RECOMMENDATION 58 olmesartan 58 Nonresidential structures 58 D aspartate NMDA receptor 58 Hamilton Anxiety Scale 58 mucosal inflammation 58 = #.#-#.# 58 angiotensin converting enzyme 58 Yards Gained Rushing 58 Technical Uptrend Reversal 58 mU L 58 mIU L 58 arterial oxygen saturation 58 malondialdehyde MDA 58 Nilotinib 58 Proc Am Soc 58 pharmacokinetic equivalence 58 ACEIs 58 PER SERVING 58 THE STAGE WAS 58 mg dosed twice 58 mEq 58 serum leptin 58 fosamprenavir 58 rHuEPO 58 Atkins dieters cardiovascular 58 carotid intima media 58 ezetimibe simvastatin 58 LV dysfunction 58 alpha TNF α 58 transaminase elevations 58 anthracycline taxane 58 HbA1c levels 58 mcg albinterferon alfa 2b 58 apolipoprotein A1 58 Jobless Claims Dip 58 LDL HDL 58 Expected Remaining 58 Arrhythmogenic 58 Combination REOLYSIN R 58 epoetin beta 58 Hypertrophy 58 EARNINGS REVIEW 58 BY OPERATOR PREPAID WHOLESALE 58 Ph + acute lymphoblastic 58 MMSE score 58 Inventory BPI 58 hemoglobin A1C 58 Gene Mutation Linked 58 pmol liter 58 isoprostane 58 primary hypercholesterolemia 58 prospectively stratified 58 nonfatal myocardial infarction MI 58 Gets Bearish Confirmation 58 ID TLR 58 Euler Hermes +#.# 58 TO OFFSET 58 autoantibody positive 58 Papillary 58 plasma lipid 58 leukocyte count 58 Physical Function 58 Index CDAI score 58 plus gemcitabine 58 SYSTEM #,#,# #,#,# [002] 58 Prostate Cancer Progression 58 tiotropium bromide 58 esophagus bladder 58 nonfatal MI 58 serum BDNF 58 Hemoglobin A1c 58 reports Q3 adj 58 % PASSENGER LOAD 58 mg d 58 nonfasting 58 events MACE 58 Engerix B 58 plus COPEGUS 58 XIENCE V demonstrated 58 BMI #-#.# 58 MARKET TALK Doha 58 PANSS 58 K ras mutations 58 anemia hemoglobin 58 serum HBV DNA 58 ADCS ADL 58 interferon alfa 2a 58 nonobese 58 naïve HCV 58 duration mediaQueryString 58 CK MB 58 SHARES UP 58 heparanase 58 tenofovir emtricitabine 58 fortified breads 58 Inc. NASDAQ DRYS 58 Viral load 58 nadroparin 58 hsCRP levels 58 aplastic anemia AA 58 Sees Q# 58 amprenavir 58 natriuresis 58 DAS# [002] 58 plasma triglycerides 58 Stainless Bar 58 Basal Cell 58 response CCyR 58 DLTR Dollar Tree 58 incidence ≥ 58 investigational saxagliptin